IPXL Financial Facts

Selling, general and administrative: 29.33M
Provision for income taxes: -6.21M
See Full Income Statement

Accounts receivable, net: 112.99M
Accrued expenses: 111.52M
See Full Balance Sheet

Impax Laboratories Inc. (IPXL) Earnings

  |   Expand Research on IPXL
Next EPS Date 5/2/14 *Est. EPS Growth Rate -160.9% *Last Qtr.
Average EPS % Beat Rate -72.6% Revenue Growth Rate -28.6% *Last Qtr.
Average % Move 1-Wk after EPS -0.2% Normal Earnings Time After Close
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. % Since Details
2/20/14 Q413 -$0.14$0.03 -$0.17$100.74M$119.01M N/A 0% Details
11/4/13 Q313 $0.00-$0.07 +$0.07$132.6M$111.83M N/A +13.7% Details
8/8/13 Q213 $0.08$0.04 +$0.04$129.63M$120.75M N/A +14.1% Details
5/1/13 Q113 $0.37$0.21 +$0.16$148.5M$128.85M N/A +37.7% Details
2/25/13 Q412 $0.23$0.19 +$0.04$141.1M$127.03M N/A +21.6% Details
10/30/12 Q312 $0.48$0.49 -$0.01$145.6M$160.76M N/A -1.7% Details
7/31/12 Q212 $0.60$0.44 +$0.16$166.5M$162.03M N/A +16.6% Details
5/1/12 Q112 $0.52$0.49 +$0.03$123.3M$163.74M N/A -2.9% Details